Qualifying P-Glycoprotein in Drug-Resistant Ovarian Cancer Cells: A Dual-Mode Aptamer Probe Approach

Chaobin Pang; Xiaolu Wang; Jichao Xu; Lei Zhang; Heng Xu; Jing Su

doi:10.2139/ssrn.4756344

Related publications

Article1983

Incessant Ovulation and Ovarian Cancer: A Critical Approach

Carlo La Vecchia, Silvia Franceschi, Giuseppe Gallus, Adriano Decarli, Alessandro Liberati, Gianni Tognoni

Article2020

Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer

Qianqian Pan, Jingjun Tian, Huihui Zhu, Liangjie Hong, Zhengwei Mao, Joaquím M. Oliveira, Rui L Reis, Xiao Li

Article2020

Abstract A75: Serine auxotrophy: A novel metabolic vulnerability of platinum-resistant ovarian cancer?

Tom Van Nyen, João Duarte, Matteo Rossi, Mélanie Planque, Esther A. Zaal, Ali Talebi, Stijn Moens, Guy Eelen, Hugo M. Horlings, Johan Swinnen, Celia R. Berkers, Peter Carmeliet, Reuven Agami, Sarah‐Maria Fendt, Diether Lambrechts, Daniela Annibali, Frédéric Amant

Article2020

Modular Peptide Probe for Pre/Intra/Postoperative Therapeutic to Reduce Recurrence in Ovarian Cancer

Jun Dai, Yong Cheng, Jun Wu, Quan Wang, Wenwen Wang, Juliang Yang, Zujin Zhao, Xiaoding Lou, Fan Xia, Shixuan Wang, Ben Zhong Tang

Article2003

Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos, Dimitrios Bafaloukos, George Fountzilas, Christos Christodoulou, Christos Papadimitriou, N Pavlidis, Haralabos P. Kalofonos, Helen Gogas, P. Kosmidis, Meletios A Dimopoulos

Qualifying P-Glycoprotein in Drug-Resistant Ovarian Cancer Cells: A Dual-Mode Aptamer Probe Approach

Discussion(0)

Open reviews(0)

Related publications

Incessant Ovulation and Ovarian Cancer: A Critical Approach

Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer

Abstract A75: Serine auxotrophy: A novel metabolic vulnerability of platinum-resistant ovarian cancer?

Modular Peptide Probe for Pre/Intra/Postoperative Therapeutic to Reduce Recurrence in Ovarian Cancer

Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer